Control of CD4 effector fate: transforming growth factor beta 1 and interleukin 2 synergize to prevent apoptosis and promote effector expansion by unknown
Control of" CD4 Effector Fate:  Transforming Growth 
Factor/~1  and Interleukin 2  Synergize  to Prevent 
Apoptosis and Promote Effector Expansion 
By Xiaohong Zhang,* Lizzie Giangreco,* H. Elizabeth Broome,~ 
Catherine M. Dargan,~ and Susan L. Swain* 
From the  "Department of Biology and the Cancer Center, and *Department of Pathology, 
University of California, San l~'egg  La Jolla,  California 92093-0063 
Summary 
The signals that determine the size and duration of the primary T  cell immune response are 
not well defined. We studied CD4 T  cells at an important checkpoint in their development: 
when they have become effectors and are ready to rapidly mediate effector functions, both via 
direct interaction with antigen (Ag)-presenting cells and via cytokine production. We deter- 
mined the effects of specific Ag and the cytokines interleukin (IL) 2 and transforming growth 
factor (TGF) 81 on T helper call type 2 (Th2) effector apoptosis versus expansion. Th2-polarized 
effector calls were generated in vitro from naive CD4 T of T cell receptor transgenic mice, and 
then restimulated with or without peptide Ag plus Ag-presenting cells and cytokines.  In the 
absence of added cytokines,  effector cells cultured without Ag died of apoptosis  after 4-7 d. 
Paradoxically, Ag both induced proliferation and high levels of cytokine synthesis and accelerated 
effector cell death. IL-2 directly induced proliferation of effectors, supported and prolonged Ag- 
induced proliferation, and partially blocked apoptosis. TGF-B did not effect proliferation or influence 
cytokine secretion, but it also partially blocked apoptosis. Together, IL-2 and TGF-/3 synergized 
to almost completely block apoptosis, resulting in prolonged effector expansion and leading to 
the accumulation of a large pool of specific effectors. When Ag and both cytokines were present, 
the effector population increased 104-10S-fold over 20 d of culture. The synergy of Ib2 and 
TGF-fl suggests that they interfere with programmed call death by distinct mechanisms. Since 
Th2 effectors are specialized to help B cells develop into antibody-secreting plasma ceils, these 
results suggest that the availability of Ag and of the cytokines IL-2 and TGF-~ is a key factor 
influencing the fate of Th2 effector cells and thus the size and duration of the primary antibody 
response. 
T 
he  response  of lymphocytes to  external  stimuli  can 
include activation of cytokine production, proliferation, 
differentiation,  and expansion or death by apoptosis (for re- 
view see references I and 2). Lymphocytes at different stages 
of development respond differentially to Ag stimulation. For 
example, as developing T cells express specific TCR in the 
thymus, they change from rapidly proliferating cells to small 
resting cells that express a default program for apoptosis un- 
less they undergo positive selection (3). These same T cells 
are susceptible to activation-induced cell death (AICD) 1 if 
they recognize Ag with high avidity (negative selection) (4). 
In contrast, mature naive T cells persist for several weeks in 
situ without Ag stimulation (5, 6). Appropriate Ag stimu- 
1 Abbreviations used in this paper: AICD, activation-induced cell death; FL, 
fluoresceinated; mit C, mitomycin C; PCCF, pigeon cytochrome C frag- 
ment; PI, propidium iodide; Tg, tramgenic; TdT, terminal deoxynucleotidyl 
transferase. 
lation results in Ib2 production, proliferation,  and develop- 
ment of effector T ceils (5, 7). The frequency of naive T cells 
able to recognize any particular protein Ag is -1 in 104-106 
(8). Thus, a protective response requires substantial  expan- 
sion of a few specific cells to generate a large population of 
effector cells. After infection with a replicating organism, the 
effector population must be large enough to deal with a large 
pathogen load.  On the other hand, once the Ag/organism 
has been cleared, the effectors are no longer needed and are 
taking up valuable space in the immune system, and, because 
of their potent effector functions and low activation require- 
ments (9), they are potentially dangerous. Effector responses 
in vivo (5-7) are often transient, and effectors have a short 
life span in vitro (10). Indeed, responses to some viruses are 
accompanied by high rates of T cell apoptosis (11) and "ex- 
haustion" of the immune response (12). In other studies, how- 
ever, high numbers of effectors have been generated, and 
effector responses were found to be prolonged (13). 
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been described in many recent reports (14-19).  It has been 
suggested that  II-2 and high Ag dose play key roles in in- 
ducing apoptosis, and that this is responsible for the termi- 
nation  of effector responses and also perhaps  for tolerance 
seen at high Ag dose (18).  Most of these reports have used 
Thl-polarized populations, which secrete II.-2, IFN-7, and 
TNF-ce. The conditions favoring the expansion of effector 
populations are less well defined and have not been exten- 
sively studied.  Experience in the generation of T  cell lines 
and clones indicates that II,2 and occasional Ag stimulation 
are required for the maintenance of both Thl and Th2 lines 
(for review see references 20 and 21). I1,2 plays a central role 
in T cell response, acting as the major product of naive CD4 
T, which can provide autocrine growth of responding cells. 
In many T  cell responses, the degree of T  cell expansion is 
proportional to the amount of I1,2 available, and I1,2 depri- 
vation leads to apoptosis (19,  22). 
TGF-B1 (and other TGF-B family members) have a large 
number of pleiotropic effects on T cells (for review see refer- 
ence 23).  Most studies have stressed its growth-inhibitory 
effects (23-25),  but  we  found  TGF-/3  to  have  long-term 
growth-promoting effects when it was added to naive CD4 
(26), and addition of TGF-~ to effector generation cultures 
resulted in effectors that secreted higher titers of I1,2 and ex- 
pressed a distinct phenotype more like that of memory cells. 
TGF-B also increased cell proliferation  and IFN-7 produc- 
tion  in CD8 cells  (27). 
To investigate the factors that regulate expansion of Th2 
effectors, we designed experiments to analyze the roles of Ag, 
Ib2, and TGF-/~ in effector cell recovery, proliferation,  and 
apoptosis. Effector T cells are activated cells, ready to quickly 
mediate effector function upon restimulation  without fur- 
ther differentiation (5,  8). They express high levels of adhe- 
sion and costimulatory receptors (5, 28), and they synthesize 
and secrete cytokines within a few hours of stimulation (29). 
This contrasts to resting naive and memory T lymphocytes, 
which require several days of proliferation and/or differentia- 
tion  before they attain  optimal  functionality  (8,  10).  We 
generate Th2 effectors in short-term  in vitro cultures from 
isolated, naive CD4 T cells ofTCR transgenic mice (Tg) (28), 
allowing us to use a defined Ag (a pigeon cytochrome C pep- 
tide [PCCF]) to study Ag effects in a well-defined, recently 
ex vivo model. We focus here on Th2 effectors that produce 
high levels of I1,4 and I1,5 but little I1,2 (28), allowing un- 
complicated analysis  of I1,2 effects.  Th2 effectors carry out 
unique  functions  in  immune  response,  promoting  B  cell 
differentiation and IgG1, IgA, and IgE Ab production (9). 
Moreover, the fate of Th2 effectors has received little attention. 
We report that, in the absence of added cytokines, effectors 
undergo apoptosis after several days of culture, but that Ag 
stimulation accelerates their death. However, I1-2 and TGF-~ 
synergize to dramatically block apoptosis and sustain an im- 
pressive expansion of the population.  These studies identify 
the effector stage as a key checkpoint at which the immune 
response can be either terminated or prolonged and expanded, 
and which might be amenable to therapeutic intervention. 
Materials and Methods 
Mice.  H-2  b/k or H-2  k/k Vf3/Voe11 and TCR Tg mice (28) 
were bred in the animal facilities at the University of California, 
San Diego,  and used at 3-6 mo of age. 
Reagents.  Medium for all in vitro cultures was complete RPMI 
1640 supplemented with penidllin (200/~g/liter), streptomycin (200 
/~g/liter), and glutamine (4/~M) plus 10% selected FCS from Hy- 
clone Laboratories (Logan, UT). PCCF 88-104, used as Ag in all 
experiments, was synthesized by the peptide synthesis facility at 
the University of California, San Diego, and purified by HPLC. 
Cytokines.  Recombinant  IL-2 (human,  10-20 U/ml from the 
Biological Response Modifiers Program,  National  Institutes  of 
Health, Bethesda, MD) or murine II.-2 (derived from the X63-Ib2 
line transfected with the murine I1.-2 gene [30]) were used inter- 
changeably and had equivalent effects. Porcine TGF-fll (referred 
to as TGF-fll throughout) was purchased from IL&D Systems (Min- 
neapolis, MN). Control cytokines used to standardize cytokine assays 
IL-2, Ib4, and Ib5 were purified from the X63.Ag8-653 lines trans- 
fected with the murine cytokine genes (30). Recombinant murine 
IFN-7 was obtained  from Genzyme Corp.  (Cambridge,  MA). 
Cell Preparations.  Purified naive CD4 + T cells from Tg mice 
were isolated as described previously (28). Spleen cells were passed 
over nylon columns to remove B, adherent, and activated cells, and 
then  treated with anti-CD8  and anti-HSA (J11D) plus C'. Cells 
were >90% CD4 + resting  cells with naive phenotype  (28, 31). 
APC for effector generation were prepared by T cell depletion of 
spleen cells with 2 anti-Thy 1.2 Ab (F7D5 and HO13.14),  anti- 
CD4 (RL172.4),  and anti-CD8 (HO2.2 and AD4) plus C' and 
treatment  with 50/~g/ml of mitomycin C (mit C). For restimula- 
tion of effectors, mit C-treated cells of DCEK-ICAM, a fibroblast 
line transfected with I-E  k and ICAM-1 (32), which expresses high 
levels of B7.1 (Dubey, C., M. Croft, and S. L. Swain, unpublished 
observations), was used. 
CD4 effectors  were generated as previously reported (28). Purified 
T cells (3  x  10S/ml) were cultured with APC and PCCF plus 20 
U/ml Ib2. Ib4 (200 U/ml) plus 10 #g/ml anti-IFN-7 was added 
at the start of culture to generate Th2 effectors. Effectors were har- 
vested, counted,  and washed after 4-5 d, and then recultured  at 
5  x  10S/ml viable CD4 § cells with either 1.7  x  10S/ml of APC 
plus 5 #M of PCCF (Ag/APC)  or APC alone. Additions of I1.-2 
(20 U/ml), TGF-B (1 ng/ml), or IL-2 plus TGF-B were made to 
aliquots of the second cultures. Cells in flasks (T75; Falcon Lab- 
ware, Oxnard,  CA) were split if they became concentrated.  Ac- 
cording to the design of the experiment,  recultured effector cells 
were harvested at different days, counted,  and further analyzed. 
DNA Fragmentation  Assay.  Effectors (2  x  106) were washed 
and resuspended in 15 #1 of lysis buffer (15% Ficoll, 10/zg/ml boiled 
RNase A [Boehringer Mannheim Corp., Indianapolis, IN], 0.01% 
bromphenol blue in 1 x Tris acetate/EDTA electrophoresis buffer). 
Samples were stored at  - 70~  until separation by gel electropho- 
resis. DNA ladder gels were premade in two parts: an upper part 
of 0.8% agarose with 1.25 mg/ml of proteinase K and 2% SDS, 
and a lower part of 2% agarose. Samples were run in the upper 
part at 20 V for 1 h and then in the lower part at 90 V for 3 h. 
Gels were gently agitated overnight in TE buffer (10 mM Tris and 
1 mM EDTA, pH 8.8) containing  20 #g/ml RNase and stained 
with 5/xg/ml ethidium  bromide  for 30 min.  Photographs  were 
taken under  UV light. 
Terminal Deoxynucleotidyl Transferase  (TdT) Staining  for Detection 
of Nicked DNA.  Using a method adapted from Gorczyca (33), 
effectors were harvested, stained with rat anti-murine  CD4 con- 
jugated with PE (PE anti-CD4),  fixed in 1% formaldehyde for 15 
700  Control  of CD4 Effector Fate min on ice, washed with PBS, and stored in 70% ethanol at 0-4~ 
For  analysis, cells  were  washed  and  incubated  at  1  x  106  in 
50 pl primary buffer (0.2 M potassium cacodylate,  25 mM Tris- 
HCI, pH 6.6, 2.5 mM cobalt chloride, 0.25 mg/ml BSA, 100 U/ml 
TdT, and 10 mM hiotin-16-dUTP, both from Boehringer Mann- 
heim Corp.) for 30 min at 37~  Washed samples were resuspended 
in 100 pl of secondary buffer (2.5 pg/ml fluoresceinated [FL] strep- 
tavidin, 0.1% Triton X-100, and 5% nonfat dry milk in 4x  saline 
sodium citrate buffer [Sigma Chemical Co., St. Louis, MO]). After 
30 min at room temperature in the dark, gated CD4 + cells were 
analyzed by FACScan  |  (Becton  Dickinson  and  Co.,  Cockeys- 
ville, MD). 
Cell C~cle Analysis.  Cells were stained with FL-anti-CD4, fixed 
in 60% ethanol, washed, and incubated with 10 U/ml RNase A 
and 2 #g/m1 propidium iodide (PI) as described by Nicoletti et 
al. (34). The programs MULTICYCLE and MCYCLE (Phoenix 
Flow Systems, San Diego, CA) were used for analysis. 
Cytokine Analysis.  Titers of IL-2, IL-4, IL-5, and IFN-7 were 
determined from supernatants collected 18-24 h after restimula- 
tion of effector cells as described previously (7). 
Cell Recovery  and Proliferation.  Effectors were harvested either 
after the generation culture (day 4) or after further reculture. Cell 
recovery was determined by counting the density of live, trypan 
blue-excluding cells. Cells were stained with PE anti-CD4,  and 
the percentage of CD4 + cells was determined by FACScan  |  anal- 
ysis. Fold expansion was calculated from the number of recovered 
cells divided by the CD4  in  initial  culture.  For  proliferation, 
[3H]thymidine was added for the final 12-16 h of culture, and in- 
corporation was determined on a betaplate  counter. The mean counts 
per min per culture of triplicate cultures is reported. 
4) and 4 d (day 8) and 7 d (day 11) after restimulation with 
APC is shown in Fig.  1. Th2 effectors were cultured with 
APC, with and without PCCF, and with and without recom- 
binant cytokines IL-2 and/or TGF-fl. Ib2 was added every 
2 or 3 d, while TGF-fl, PCCF, and APC were added only 
at the time of restimulation. 
CD4 T  expanded 10-fold in the Th2 effector generation 
culture. In the absence of reexposure to Ag (Fig.  1, right), 
effector recovery in cultures without cytokines was unchanged 
for >4 d  of reculture (8 d  total), but the population then 
declined, virtually disappearing over the next 3 d. In con- 
trast, effectors restimulated with 5 #M PCCF (Fig.  1, left) 
remained roughly at prestimulation levels, even though Ag 
stimulation led to high levels of Ib4 secretion and prolifera- 
tion (see Figs.  4, 6, and 7).  Addition of TGF-fl alone had 
no effect on cell recovery in "no Ag" cultures but led to an 
approximately twofold increase in recovered cells in cultures 
with Ag. Addition of Ib2 led to dramatic effector expansion 
in both PCCF and no Ag cultures. II~2 directly supported 
expansion of effectors but became less effective in supporting 
proliferation after 4 d. Without Ag, the IL-2-driven popula- 
tions died off within another week (not shown). Expansion 
in the absence of Ag, but with II,-2, was approximately five- 
to seven-fold. IL-2 and Ag together supported greater expan- 
sion.  Addition  of TGF-fl  to  IIr  cultures 
resulted in expansion that was just slightly greater than with 
IL-2 alone approximatdy two- to threefold in the series of 
experiments) for the first 4 d, but subsequent recovery showed 
Results 
Experimental Design.  All experiments had the same basic 
design. Th2 effectors were generated in vitro, harvested, and 
divided into groups for reculture. Aliquots were restimulated 
with APC, with or without PCCF, with either: no cytokine, 
Ib2 alone, TGF-fl alone, or both. Recovered cells were ana- 
lyzed at different times after restimulation as indicated. Tg 
CD4 cells are almost all naive (31), and after 4-5 d of stimu- 
lation they develop into a population of effectors (as judged 
by their functional activities and phenotype) (28). This first 
culture routinely results in a 10-fold increase in cells under 
standard conditions (Ib2 added at 20 U/ml) (see Fig.  1) and 
a much larger increase in the per-call capacity for the secre- 
tion of IL-4 (28).  The mit C-treated APC used to generate 
effectors disappear by the end of culture. The APC used to 
restimulate the effectors also disappear rapidly, constituting 
<5% of recovered cells at 24 h and <1-3%  thereafter (not 
shown). We focus here on Th2 effectors by adding Ib4 (plus 
anti-IFN-'y)  to  the  generation cultures,  which results  in 
effectors polarized for Th2 cytokine production (10, 28, and 
see Figs. 6 and 7). The effectors were routinely analyzed by 
staining and were invariably CD4 +, Tg TCR + cells with an 
activated phenotype including high  expression  of CD44, 
CD45RB,  and IL-2R (28). 
Effect of Ag Stimulation and Cytokines 11.,2 and TC,  F-B on 
Effector Expansion.  A  representative analysis  of live CD4 
recovery at the end of the effector generation culture (day 
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Figure 1.  Effects  of Ag and cytokines  on effector  expansion. Tg +  , Th2 
effector cells were generated as described in Materials and Methods. 5 x 
10S/ml effectors  were recultured with 1.7 ￿  10 S/ml APC (mit C-treated 
DCEK-ICAM) in the presence (/eft) or absence (right) of PCCF (5/~M). 
Replicate groups were harvested 4 and 7 d hter. Expansion of CD4 T 
cells was calculated by determining the viable CD4 recovery and com- 
paring it with the original Dumber of naive CD4 cells cultured at day 
0. Effectors were recultured with: no additional cytokine (0), 20 U/ml 
of I1..2 (A), I ng/ml of TGF'-B (I), or both TGF-B and IL-2  (A) added 
at the beginning of  restimuhtion. IL-2  was given when fresh medium was 
added. Results are representative of three similar experiments. 
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lation),  Ag-stimulated  effectors that received periodic II.-2 
and treatment with TGF-B at day 4 had expanded >30-fold 
(an expansion of 300-fold  from the culture of naive cells). 
Similar levels of expansion have been observed in three ex- 
periments with Th2 effectors. The positive effects of Ag stim- 
ulation, Ib2, and TGF-B on effector expansion have been seen 
in  six  experiments. 
Effect of Ag Stimulation, 11_,2, and TGF-~ on Effector Apop- 
tosis.  Net expansion of cells is a function of both increased 
number due to division and loss due to death. To assess the 
effects of Ag and cytokines on apoptosis, we compared the 
levels of DNA fragmentation in groups of naive CD4 T cells, 
fresh Th2 effector cells at day 4, and effector cells restimu- 
lated for 2, 4, or 7 d. We compared groups of effectors re- 
stimulated with Ag plus APC (Fig. 2, top) with those stimu- 
lated with APC alone (Fig. 2, bottom). Cells at each of these 
time points  were >95%  CD4 §  cells. 
DNA  from  fresh, naive cells  and from  freshly  isolated 
effectors was  largely  intact.  DNA  of recultured effectors 
without Ag or cytokines  (Fig.  2,  bottom) remained largely 
intact for 4 d, with ladders appearing by day 7. DNA from 
Figure  2.  Effects  of  Ag  and 
cytokines on DNA fragmentation. Th2 
effectors  were  recultured  with  or 
without Ag and cytokines as described 
in Fig. 1. After 2, 4, and 7 d of recul- 
ture, the DNA was extracted from 2  x 
106 cells from each group and run on 
gels  for  detection  of DNA  ladders. 
DNA  from fresh  Th2  effectors  (E), 
from fresh naive CD4 T cells (Na), and 
from a sample of APC (A) were also 
analyzed. DNA from fresh thymocytes 
(negative;  N)  and  from  thymocytes 
treated with dexarnethasone (positive; 
P) were included as controls.  Effector 
cells were cultured with: no additional 
cytokines,  IL-2 at 20 U/ml, Ib-2 and 
anti-TGF-~ (5  #g/ml)  (indicated by 
asterisk), TGF-~ at 1 ng/ml, or "I'GF-B 
and IL-2. Results are representative of 
three  similar experiments. 
702  Control of CD4  Effector Fate PCCF-stimulated cells with no cytokines showed marked 
DNA ladders by 2 d of culture, which peaked at day 4 and 
continued to be prominent at day 7 (Fig. 2, top). Thus, Ag 
stimulation accelerated the rate of cell death. It should be 
noted that, in repeat experiments, maximum DNA fragmen- 
tation in Ag-stimulated cultures occurred slighdy later, around 
day 4 (see Fig. 3), suggesting that Th2 effector cells undergo 
quite delayed apoptosis, even after stimulation with Ag. The 
level of Ag used here for restimulation (5/~M) is a level that 
stimulates optimum proliferation and cytokine secretion from 
both naive and effector CD4 T, but similar levels of apop- 
tosis were seen at 10-fold lower and higher levels of PCCF 
(see Fig.  6). 
In cultures with or without Ag, addition of I1:2 led to 
decreased DNA laddering at days 4 and 7. Addition of TGF-3 
decreased fragmentation early but on its own had little effect 
later. TGF-B is a ubiquitously produced cytokine, so we also 
tested whether Ab to it would block the effect of I1:2. A 
slight enhancement of laddering was seen only at 7 d in cul- 
tures both with and without Ag. Dramatically, addition of 
TGF-B with I1:2 was able to prevent all detectable fragmen- 
tation in Ag-stimulated as well as in no Ag effectors. In fur- 
ther studies we have concentrated on the effects of cytokines 
on PCCF-stimulated effectors, because the effects are more 
dramatic, but the effects of II.-2 and TGF-B in blocking apop- 
tosis are also consistently seen when no Ag is present. 
To better quantitate the DNA changes associated with apop- 
tosis, we used the TdT UTP nick-end labeling method to 
visualize nicks in the DNA. Permeabilized cells were treated 
with TdT plus biotinylated dUTP followed by FL-avidin, al- 
lowing an assessment of the percentage of stained, apoptotic 
cells. Groups of restimulated Th2 effector populations were 
analyzed 2, 4, and 7 d after reculture with Ag. TdT staining 
of CD4 +-gated cells is shown in Fig. 3. In cultures without 
cytokines, nicked DNA was detectable in 18% of the CD4 + 
population by 2 d and was apparent in >40%  of the cells 
harvested at 4 d and >80%  at 7 d. Addition of either I1:2 
or TGF-B led to a reduction in cells with nicked DNA at 
4 and 7 d after restimulation. The effects of the combination 
of I1:2 and TGF-B were dramatic. At 2, 4, and 7 d, only 
•10%  of cells in cultures receiving both cytokines showed 
evidence of damaged DNA.  Thus, I1:2 plus TGF-B treat- 
merit of effectors led to prolonged resistance to AICD. Similar 
protection was achieved in non-Ag-stimulated Th2 effector 
cultures, although the TdT staining increased more slowly 
(not shown). 
Kinetics of Cytokine Effects on Cell Cycle Progression  and Prolifer- 
ation.  To analyze possible mechanisms involved in Ig2 and 
TGF-~ effects, we analyzed  the kinetics of DNA synthesis 
and cell cycle progression of Ag-restimulated Th2 effectors. 
Effectors were harvested after 0,  1, 2, and 4 d and stained 
with PI, and the proportion of cells in G0/G1, S, G2, and 
M was determined. Fig. 4 (left) shows the total fraction of 
cycling effectors. The distribution of cells in each of the phases 
of cycle was proportional in each group (not shown). Before 
restimulation, approximately one-third of the cells were ac- 
tively cycling (day 0), compared with <5% among naive CD4 
T (not shown). Ag stimulation led to a large increase in the 
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2 days  4 days  7 days 
DNA Strand Breaks Associated  with Apoptosis 
Figure 3.  Effects ofcytokines on DNA nick formation in Ag-stimuhted 
Th2 effector cells. Th2 effector cells were restimuhted with PCCF (5 #M) 
and APC with no additional cytokine (NONE,  top), II:2 (20 U/n-d), TGF-3 
(1 ng/ml), or TGF-3 plus Ib2. After 2, 4, and 7 d of reculture,  cells were 
stained with the enzyme TdT, biotinylated dUTP, and PL-strepta~din. 
PE-conjugated anti-CD4 was used to counterstain. Histograms represent 
the log FL (TdT staining) of CD4 positive cells, analyzed by FACScan  | 
Lysis II software (Becton Dickinson and Co.). The percentage  of CD4 
cells falling within the indicated negative (determined by omitting the 
TdT) and positive gates is indicated in each histogram. The results  are 
representative  of three similar experiments. 
fraction of cells in active cycle 1 d later (day 1), regardless 
of cytokines added. No increase is seen in cultures not receiving 
Ag (not shown). Over the next 3 d, the proportion of cy- 
cling cells decreased in each group. Cultures without II:2 
had <20% cells in cycle by day 4, whereas significantly more 
were found in I1:2-treated cultures. The highest proportion 
of cycling cells at days 2-4 were found in the I1:2 plus TGF-fl 
group. In some models, TGF-B has been shown to cause cell 
cycle arrest, especially in G1, and suppression of cell growth 
(35-37).  In this case, TGF-~ did not cause cell cycle arrest 
in G1, nor did it slow cell cycle progression. 
DNA synthesis, commonly  used as an indicator of"prolffer- 
ation,' was analyzed in cultures ofeffectors restimulated with 
(Fig. 4, middle) or without (Fig. 4, right) PCCE With Ag, 
effectors incorporated/adiolabel with or without cytokines 
at days 1 and 2 (presumably responding to the I1.-4 they se- 
crete), but the I1:2-supplemented groups had prolonged syn- 
thesis of DNA. Effectors in cultures without PCCF (which 
produced no endogenous cytokine) synthesized little DNA 
(Fig. 4 C). I1:2, but not TGF-B,  directly supported DNA 
synthesis of non-Ag-stimulated cells. Thus, TGF-fl did not 
directly promote growth of the Th2 effectors, but it prolonged 
I1:2-supported proliferation. 
11-,2 and TC,  tZ~ Synergize over a Broad Range of Doses.  In Cell Cycle Progression 
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Figure 4.  Kinetics  of cytokine  effects. Th2 effectors 
were restimulated  and divided  into groups for analysis  of 
cell cycle  progression at days  0, 1, 2, and 4 and prolifera- 
tion at days 1, 2, and 4. For analysis  of cell cycle (left), 
effectors were analyzed  immediately  (day  0) or after re- 
stimulation  with PCCF (5/~M) plus APC with the indi- 
cated  cytokine  additions:  none  (0), IL-2  (A), TGF-/3  (m), 
or both TGF-B  and IL-2 (A), for 1, 2, or 4 d. Cells were 
stained with PI (and PE-CD4), and the fraction  of gated 
CD4+ cells  in G0/G1, S, C~, and M was determined.  The 
left panel shows the combined percentage in S, G2, and 
M. The portion of cells in each of the phases of active 
cycling  was very  similar  for each group (not shown). For 
proliferation  (DNA synthesis),  effectors  were  restimulated 
with PCCF plus APC (middle) or APC alone (right). 
Radiolabel was added during day 1, day 2, or day 4 of 
culture, and incorporation was determined after 18 h. 
some cases, high doses of II.-2 have been found to promote 
rather than inhibit apoptosis (17, 18), so we investigated the 
effects of IL-2 dose (Fig. 5). Th2 effectors were restimulated 
for 4 d in the presence  of different amounts of IL-2, with 
or without TGF-/3. Representative results of two experiments 
are shown in Fig. 5.  Doses of II-2 from 0.6 to 600  U/ml 
led to enhanced effector cell recovery (not shown) and de- 
creased apoptosis.  Moreover, addition of TGF-~ at each dose 
markedly enhanced the antiapoptotic effect of II:2, indicating 
synergy between the two factors. We also compared different 
doses of TGF-B added to a constant dose of IL-2 (20 U/ml) 
for effects on Ag-stimulated cultures. Addition of TGF-~ at 
10,  1,  and 0.1  ng reduced apoptosis as indicated by DNA 
fragmentation when I1.-2 was present, and each of these doses 
also reduced fragmentation in the absence of Ib2 (not shown). 
60 
50 
[,m  40 
~.  3o 
~h  ~  2O 
[,,, 
1 
~  lo  ~  alone 
t  plus TGF-13 
lo o  to1  lo  z  lo  3 
IL-2 Units/nil 
Figure 5.  Effects  of IL-2  concentration.  Th2 effector  ceUs were  restimu- 
lated with PCCF plus APC plus IL-2  added  in amounts  ranging  from  0.6 
to 600 U/ml, with (A) or without (A) TGF-B (1 ng/ml). After 4 d, 
cells from each group were stained with PE-CD4 and counted. Nicked 
DNA was determined as in Fig. 3, and the percentage of TdT-positive 
CD4+ T cells is shown. 
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IL-2 at 20 U/ml and TGF-fl at 1-10 ng/ml were optimally 
effective and are the standard doses used in our experiments. 
Effect of Ag Dose on Effector Fate.  Since high Ag dose has 
been suggested to favor activated T  cell apoptosis (18), we 
compared the effect of PCCF dose on apoptosis,  Ib4 pro- 
duction, and DNA synthesis, each measured 2 d after restim- 
ulation. Results are shown in Fig. 6. TdT staining, II-4 produc- 
tion,  and  DNA  synthesis each  increased  with  Ag  dose, 
becoming maximum in the range of 1-10 pM PCCF. Thus, 
induction of each of these responses occurred at comparable 
Ag doses. 
Effects of lL2 and TGF-I~ on Cytokine Production.  Effectors 
rapidly synthesize and secrete high titers of cytokines in an 
Ag-dependent  fashion  (29).  Cytokines  secreted  by  Ag- 
stimulated Th2 effectors could potentially act to drive sus- 
tained proliferation and protect effectors from apoptosis.  IL-4 
is a growth factor for effectors (Swain, S. L., unpublished 
observations) as weU as Th2 cell lines. Thus, IL-2 and/or TGF-B 
might function by altering the pattern or amount of effector 
cytokines. To assess this possibility,  Th2 effectors were re- 
stimulated with Ag and with or without IL-2 and/or TGF-/3. 
After 24 h, effectors were harvested, washed to remove added 
cytokines, and recultured. Supernatants from each group were 
harvested after 18 h, and titers of IL,2, IFN-'y, IL-4, and Ib5 
were determined. As shown in Fig. 7, effectors in each group 
made a Th2 pattern of cytokines: high titers of IL-4 and Ib5 
and low to undetectable titers of IL-2 and IFN-7.  II:2 and 
Ib2 plus TGF-/~ increased cytokine production slightly, but 
there was no change in the relative ratios of the different 
cytokines. Similar results were seen in supernatants collected 
in the first 24 h and from cells treated with cytokines for 
2 or 4 d (not shown). Addition of exogenous IL,4 did not 
block apoptosis (not shown). 
Prolonged Effects of TGF-I~ Treatment on Long-term Effector 
Expansion.  Since IL-2 and TGF-/3 together effectively  block 
apoptosis,  and since IL-2 sustains  proliferation of activated 
T cells, we reasoned that effector cells periodically restimu- 
lated with Ag, Ib2, and TGF-/~ might be able to undergo 
many rounds of proliferation. To test this prediction, Th2 
effectors were generated, harvested,  and counted after 6 d and 8 
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Figure  6.  Effect of Ag dose on effector re- 
sponse.  Th2  effectors  were  recultured with 
PCCF at doses ranging from 0.01 to 100/~M 
with APC but no cytokines.  After 2 d groups 
were harvested, and groups were then stained 
with TdT as a measure of apoptosis (left);  su- 
pernatant was harvested and assayed for IL-4 
by  ELISA  (middle);  or  [3H]thymidine  was 
added and incorporation was determined for 
the final  18 h  (right). 
restimulated with Ag/APC plus either IL-2 alone or IL-2 plus 
TGF-3. Recovery was determined after 12 d, and, after 14 
d, cultures were harvested and counted again, and an aliquot 
was restimulated with Ag/APC. Fresh medium with Ib2 was 
added whenever cultures became dense. Cultures were har- 
vested after 20 d. At each harvest time CD4 recovery was 
determined. The long-term effector expansion shown in Fig. 
8 was truly impressive. After 20 d, Th2 effectors, stimulated 
with TGF-B at day 6, had expanded ~>15,000-fold compared 
with the number of naive CD4 T cultured at day 0. Without 
TGF-B, total expansion was severalfold  less. In other experi- 
ments, it was found that the addition of TGF-3 at least one 
more time late in culture gave additional  increases in CD4 
effector recovery (not shown). At all time points the effector 
populations made impressive  amounts of  appropriate cytokines 
when restimulated with Ag/APC (not shown).  It was par- 
ticularly striking that the effects of TGF-3 added only at day 
6 were still detectable 2 wk later. 
Fig.  7.  Effects of cytokines on cytokine production. Th2 effectors were 
restimulated with PCCF plus APC for 1 d with no cytokine, with II:2, 
with TGF-B, or with both Ib2 and TGF-3, as indicated. After that incu- 
bation, cells were washed and restimulated with PCCF and APC without 
cytokines.  Culture supernatants were harvested 24 h later, and IL-2, IFN- 
%  II.-4, and IL-5 titers were determined. 
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Figure  8.  Effect  of cytokines on long-term effector  expansion. Th2 
effectors were generated. After 6 d, 5  x  10S/ml effector cells were recul- 
tured with PCCF plus APC in the presence of 20 U/ml of Ib2 (A) or 
Ib2 plus 1 ng/ml of TGF-~ (A). TGF-B was added only at day 6.  Ib2 
was added periodically when fresh medium was used. Cells were counted 
at 12 and 14 d. Aliquots of harvested cells were restimulated by PCCF 
plus APC at day 14, and cells were harvested again after a total culture 
of 20 d.  Cell recovery,  calculated by determining the number of CD4 
projected if all effectors were recultured on clay 14, was compared with 
the number of naive cells to calculate  effector  expansion over the entire 
culture period. Discussion 
The mechanisms underlying expansion and contraction of 
Ag-specific lymphocytes during immune response and the 
conditions that regulate the denouement or prolongation of 
the response have received far less attention than those factors 
that promote its initiation. Results from the experiments in 
this paper suggest that the effector stage is an important check- 
point for regulation of the size and duration of the primary 
response of CD4 T cells, and that the Th2 effector popula- 
tion can either be programmed or induced to die of apop- 
tosis or can expand up to 1,000-fold over the next 2 wk. The 
experiments dearly identify several factors that regulate these 
fates of CD4 effector cells, including: (a) Ag stimulation, 
which promotes proliferation, cytokine production, and apop- 
tosis, with the outcome of its effects depending on the pres- 
ence of other factors; (b) IL-2, which supports expansion and 
also participates in blocking apoptotic death; and (c) TGF-fl, 
which synergizes with II.-2 to block apoptosis and promote 
effector expansion, but which does not act as a growth factor. 
Thus, it appears that the array of signals that impinge on 
recently generated effector cells will determine whether the 
Th2 response is terminated or prolonged and increased, and 
that this stage of an immune response may be one at which 
therapeutic intervention is particularly relevant.  While re- 
cent studies have focused on the conditions favoring exhaus- 
tion of effector responses by induction of apoptosis (14-19), 
the current study supports the concept that conditions can 
also be found that favor the opposite outcome of expanded 
response. 
Ag-specific, Th2-polarized effectors generated in vitro from 
naive CD4 cells of TCR Tg mice were used to examine the 
consequences  of restimulation with Ag, IL-2, and TGF-fl. 
Effectors carry out their functions of cytokine production and 
helper function rapidly after restimulation (10, 29) and are 
easily detected after primary Ag injection in vivo as well as 
in vitro (7), attesting to their physiological relevance. Transfer 
of identical populations to adoptive hosts results in the de- 
velopment of long-term CD4 memory, indicating their poten- 
tial for further development (28).  Here we monitored the 
kinetics of effector expansion, cytokine production, DNA 
synthesis,  cell cycle progression, and apoptotic death. 
Ag stimulation induced each response, including produc- 
tion of high titers of specific cytokine by 24 h (Figs. 6 and 
7; 28), entry into cell cycle and DNA synthesis (Fig. 4) within 
1 d, and a delayed apoptosis (AICD), which commenced  after 
the burst of cytokine production at 2-4 d (Figs.  1 and 2). 
Thus, in the absence of interfering cytokines, restimulated 
effectors synthesized and secreted cytokines and underwent 
cell division but did not expand in number (Fig. 1), because 
a majority of the population was dead or dying by 4 d. It 
is likely that TCR triggering induced expression of compo- 
nents of an apoptotic pathway,  a result reported previously 
for bulk-activated T cells and Thl lines (14-17). The AICD 
ofTh2 effectors is considerably slower than that reported for 
cell lines or hybridomas (38). The dose of Ag optimal for 
each of these was comparable (Fig. 6), supporting a model 
in which common signal transduction events are shared by 
the different pathways (38). Critchfield et al., reported that 
apoptosis in Thl clones and recently activated CD4 T ceils 
was most evident at high Ag dose (18). These results suggest 
a paradigm in which effectors reencountering Ag but not 
receiving additional signals will carry out their effector func- 
tions and then die of apoptosis. This phenomenon is liable 
to be largely responsible  for the apparent exhaustion of re- 
sponses to viruses that remain present at high titers (12) and 
also to cases of high dose tolerance, as described by Lenardo 
and co-workers (18). It can also be postulated that this kind 
of mechanism of exhaustion of responses  to persisting Ag 
may be an important component of protection against auto- 
immunity. 
Interestingly, effectors not exposed to Ag survived several 
days and only then began to die of apoptosis, causing the 
loss of the effector population after 4-8 d of culture (Fig. 
1). This in vitro data parands the kinetics of an in vivo re- 
sponse to a soluble protein such as KLH, which shows a sharp 
peak of effector function at days 4-7, with a decline after 
that to baseline levels by day 14 (8).  Thus, in the absence 
of Ag or other mitigating factors,  the effector population 
is short lived and the response is transient.  This kind of 
phenomenon would provide a natural termination of the 
effector respon.~e  once the response had succeeded in dealing 
the organism or Ag that initially induced it. 
The most novel finding is that TGF-~ and ID2 can syner- 
gize to prevent the apoptotic death (Figs. 2 and 3) of Th2 
effectors, leading to prolonged expansion of the effector popu- 
lation (Figs. 1 and 8). Both Ib2 and TGF-~ alone were able 
to partially block apoptosis. I1.-2 is the major growth factor 
for T cells, directly supporting cell cycle progression in acti- 
vated T  cells expressing II.,2R (20) such as effectors. Acti- 
vated lymphocytes are  often addicted to  growth factors, 
sufering apoptotic death when they are withdrawn (for re- 
view see references 19 and 39). This appears to be the case 
for activated T cells, which, in a number of models, die un- 
less Ib2 is provided (22), and it is seen here for Th2 effectors. 
Prolonged, dramatic expansion of Thl effectors was also seen 
under the same conditions (not shown). 
Recent studies of Critchfield et al. described a facilitating 
effect of II.-2 in the apoptosis of in vitro activated  CD4 T 
cells and Thl clones (18). They found that the degree of apop- 
tosis was correlated with the amount Ib2 during the first 
stage of culture and restimulation and that Ib2 was neces- 
sary for the apoptosis of a Thl done. Those results are in 
apparent contrast to the results reported here for Th2 effectors. 
We observed that Ib2, as expected, directly induced DNA 
synthesis of effectors, and enhanced cell cycle progression (Fig. 
4), but here it led to a decrease in DNA laddering in both 
Ag-stimulated and unstimulated effectors (Fig.  2), as well 
as a decrease in the proportion of cells with damaged, nicked 
DNA (Fig. 3). At no concentration we tested, from 0.6 to 
600 U/ml of 1I.,2, did the addition of II.-2 increase apoptosis 
(Fig. 5). Presumably as a consequenceof these effects, Ib2, 
when present continuously, supported impressive expansion 
of effectors (Figs. 1 and 8). Several factors could explain the 
apparent differences between that report and the results here. 
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be differences between the two subsets. Indeed, we have noted 
some differences between Thl and Th2 effectors within the 
first few days after restimulation (Zhang, X., and S. L. Swain, 
unpublished observations).  Second, we have analyzed expan- 
sion over a longer time frame. Further experiments will be 
needed to determine which of these factors accounts for the 
difference in results. We are currently exploring whether Thl 
effectors behave more like the Thl lines and undergo rapid, 
Ib2-dependent apoptosis. 
In some models, apoptosis occurs preferentially during a 
particular phase of cell cycle such as G1 (35,  36),  G2 (39), 
or S (40), although others report no such dependence (15, 
19). IL-2 did not seem to protect effectors merely by driving 
them through cell cycle, since Ag stimulation, which was 
as efficient in driving cell cycle progression and DNA syn- 
thesis (Fig. 4), resulted in high levels of apoptosis. Moreover, 
the addition of IL-4, which also supports proliferation, did 
not block apoptosis (Zhang, X.,  and S. L. Swain, unpub- 
lished observations), and the stimulated Th2 effectors made 
abundant Ib4 (Fig.  6). 
Particularly striking is the unexpected ability of TGF-B 
to block apoptosis.  TGF-~ is a highly pleiotropic cytokine 
with multiple positive and negative effects on growth and 
differentiation of a wide range of cell types. The TGF-B family 
and other related cytokines are noted for their effects on cell 
differentiation (41, 42). In the immune system it is best known 
for its negative effects on T and B cell proliferation (23-25) 
and its ability to drive B cells to switch to the IgA isotype 
oflg (43). TGF-B has even been reported to induce apoptosis 
of some kinds of cells (44,  45).  The effects of TGF-~ thus 
seem to differ with the cell type and/or the stage of differen- 
tiation, and it has been suggested that it acts as a kind of 
switch to change whatever pattern of differentiation is cur- 
rently in place (25). We found earlier that TGF-B had a series 
of interesting effects when it was added during effector gener- 
ation. Addition of TGF-B enhanced the ability of effector 
populations generated to produce IL-2 and caused them to 
down-regulate CD45RB, an isoform of the intracytoplasmic 
CD45 phosphatase expressed on activated effectors but not 
on resting memory cells (26). Effectors generated in the pres- 
ence of TGF-~/also grew better in IL-2-containing medium 
than did those ceils that were never exposed to TGF-B.  In 
studies of CD8 cells, similar effects of TGF-B were noted 
(27).  The effects of TGF-~/did not appear  to be mediated 
in this instance via a shift in production of the cytokines Ib2, 
IFN-3,, IL-4, and Ib5, commonly used to subdivide Thl and 
Th2 effectors (Fig. 7). Of course, we cannot rule out an in- 
direct effect via untested cytokines. 
TGF-~/alone partially blocked apoptosis of effectors and 
synergized with IL-2 to almost completely block apoptosis 
(Figs. 2 and 3). TGF-~/alone modestly increased effector cell 
recovery, but, in contrast to II~2, it did not act as a direct 
proliferation factor for unstimulated effectors (Figs. 1 and 4). 
This supports the hypothesis that TGF-~ acts to block apop- 
tosis via a different pathway from IL-2. Prolonged protection 
from apoptosis required Ib2. The relevance of the antiapop- 
totic effects is seen in the fact that, when both IL2 and TGF-~/ 
were added, effectors were able to undergo multiple rounds 
of expansion, yielding populations 10,000-100,000-fold  the 
size of the naive ceU population (Fig. 8). Substantial growth 
also occurred in non-Ag-restimulated cultures, but total ex- 
pansion was less and expansion was evident for a shorter time. 
These observations identify for the first time a set of factors-Ag, 
IL-2, and TGF-B-that can work together to promote exten- 
sive expansion of an effector population in vitro, without the 
period of massive death or "crisis" that usually accompanies 
the development of Ag-specific cell lines and clones. 
The mechanism(s) of the TGF-B and II~2 actions are not 
yet dear. Since effectors die in the absence of further stimula- 
tion, it seems likely that many of the components of the apop- 
totic pathway are already present and/or are constitutively 
produced, and that the action of TGF-~/and perhaps Ib2 
might include synthesis of products that block those com- 
ponents. Preliminary studies showed that Bcl-2, a protein im- 
plicated in blocking programmed death (1, 2), is found at 
reduced levels in Ag-stimulated effectors, and that treatment 
of effectors with either TGF-~ or Ib2 led to increased main- 
tenance of Bcl-2  levels (Zhang, X.,  L.  Giangreco, H.  E. 
Broome, and S. L. Swain, unpublished observations).  We are 
currently studying in  more detail  the effects  of Ag  and 
cytokines on Bcl-2 and its family members to try to pinpoint 
how each cytokine may be functioning. Other aspects of the 
mechanism of apoptosis and its suppression, including the 
potential role of the Fas pathway, are also being investigated. 
We suggest that the effector phase of a T  cell response 
is an important checkpoint at which very different outcomes 
are possible.  The potential impact of the different effector 
cell fates on in vivo immune response is great. Extrapolating 
from the in vitro studies, we would predict that the effector 
phase of a specific response can be either quite small and very 
short if Ag is rapidly cleared or if Ag is present but has failed 
to generate local cytokine levels of sufficient magnitude. On 
the other hand, if Ag levels continue to be high and a vig- 
orous CD4 response including production of cytokines such 
as TGF-B and IL-2 occurs, effectors could continue to expand 
and function. It is likely that other factors that also regulate 
these decisions will be found, and it can be predicted that 
these might include not only other cytokines but also signals 
delivered by various costimulatory pathways during interac- 
tion of T  cells with APC. Since many pathogens replicate 
rapidly, this would seem to be a useful mechanism to ensure 
that effector populations sufficiently large to effectively con- 
trol the pathogen would be generated. Moreover,  it might 
prove feasible to design forms of immune intervention at the 
time of effector response to a pathogen or after vaccination 
and to develop strategies either to exhaust unwanted responses 
or to enhance those that are desired. 
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